Phase 1 Study of Ixabepilone in Combination With Cisplatin in Subjects With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2016
At a glance
- Drugs Ixabepilone (Primary) ; Cisplatin
- Indications Non-small cell lung cancer; Solid tumours
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 26 Mar 2012 Actual number of patients changed from 29 to 30 as reported by ClinicalTrials.gov.
- 03 May 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 03 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.